| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/20/2011 | US20110014213 Human anti-alpha 9 integrin antibody |
| 01/20/2011 | US20110014201 Il-18 receptor antigen binding proteins |
| 01/20/2011 | US20110014193 Humanized anti-human alpha 9-integrin antibody |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110014117 Anti-igf1r |
| 01/20/2011 | CA2768247A1 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
| 01/20/2011 | CA2768241A1 A mechanism and method for regulating glycogen synthase kinase 3 (gsk3)-related kinases |
| 01/20/2011 | CA2767760A1 Process and system for obtaining botulinum neurotoxin |
| 01/20/2011 | CA2767570A1 Mutated sumo isoforms and uses thereof |
| 01/19/2011 | EP2275818A2 Method for improved early recognition of the seroconversion of an antibody to hepatitis C |
| 01/19/2011 | EP2275575A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275574A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275559A2 Optimized messenger RNA |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275541A2 Method for controlling the activity of immunologically functional molecule |
| 01/19/2011 | EP2275540A2 Method for controlling the activity of immunologically functional molecule |
| 01/19/2011 | EP2275537A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| 01/19/2011 | EP2275536A1 AP1 amine oxidase variants |
| 01/19/2011 | EP2275530A2 Method for cultivating cells for the production of compounds |
| 01/19/2011 | EP2275450A1 Treatment with anti-ERBB2 antibodies |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275448A2 Monovalent antibody fragments useful as therapeutics |
| 01/19/2011 | EP2275446A2 Antibodies to insulin-like growth factor I receptor |
| 01/19/2011 | EP2274437A2 Compositions and methods for detecting egfr mutations in cancer |
| 01/19/2011 | EP2274428A1 Isolated peptides having phospholipase inhibitory activity |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1492874B1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
| 01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
| 01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 01/19/2011 | EP1132475B1 Novel serine protease bssp2 |
| 01/19/2011 | CN1468304B Method of producing functional protein domains |
| 01/19/2011 | CN101952454A Anti-IFNAR1 antibodies with reduced Fc ligand affinity |
| 01/19/2011 | CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 01/19/2011 | CN101952428A Mutant pyrrolysyl-tRNA synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
| 01/19/2011 | CN101952426A Anti-BST2 antibody |
| 01/19/2011 | CN101952303A Method for increasing expression yield of a protein of interest |
| 01/19/2011 | CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 01/19/2011 | CN101951946A Human antibodies that bind mesothelin, and uses thereof |
| 01/19/2011 | CN101948900A Method for extracting hydrolyzed collagen from bovine cartilage |
| 01/19/2011 | CN101948899A Method for preparing angiotensin converting enzyme inhibitory peptide (ACEIP) by using enzymatic degradation on mussel-digested protein |
| 01/19/2011 | CN101948898A Method for preparing nano oligopeptide collagen |
| 01/19/2011 | CN101948897A Method for extracting shinyleaf yellowhorn oil, shinyleaf yellowhorn polysaccharide and shinyleaf yellowhorn protolysate peptide from shinyleaf yellowhorn |
| 01/19/2011 | CN101948896A Integrated preparation method of multi-function milk casein active peptides |
| 01/19/2011 | CN101948895A New method for development and utilization of potato residue resource |
| 01/19/2011 | CN101948894A Gradient dilution feed enzyme membrane coupling reaction and application thereof for preparing scale collagen polypeptide |
| 01/19/2011 | CN101948893A Method for producing nisin by continuous fermentation |
| 01/19/2011 | CN101948892A Method for producing Nisin A by fermenting pure plant materials without transgenic components |
| 01/19/2011 | CN101948891A Culture medium for preparing Bacillamide C by fermenting and shrinking bacillus as well as preparation and application method thereof |
| 01/19/2011 | CN101948890A Production method of chicken interferon alpha and constructed engineering bacteria |
| 01/19/2011 | CN101948845A Optimization gene for coding chicken interferon alpha and application thereof in preparing chicken interferon alpha |
| 01/19/2011 | CN101948841A Epitope sequences |
| 01/19/2011 | CN101948543A Fusion protein and coding gene and application thereof |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948524A Multi-phosphopeptide-enriched casein hydrolyzate and preparation method thereof |
| 01/19/2011 | CN101603026B Animal origin-free low-protein culture medium suitable for animal cell product production |
| 01/19/2011 | CN101591622B Melittin gene fission yeast engineering bacteria and construction method and application thereof |
| 01/19/2011 | CN101126104B Method for preparing natural active collagen by using acid-enzyme composite |
| 01/18/2011 | US7872111 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby |
| 01/18/2011 | US7872110 Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 01/18/2011 | US7872108 Using centrifugation and filtration to recover protein aggregates comprisng metallic nanoclusters for use as apototic therapeutic in treatment of cell proliferative disorders |
| 01/18/2011 | US7872104 Antibody, immunoassay and method for prostate cancer detection |
| 01/18/2011 | US7872102 Anti-IL-23 antibodies |
| 01/18/2011 | US7872096 ligating recombinant intein domains to a linear synthetic protein to form a compound D1-X(n)-D2, where D1 and D2 are catalytic domains of an intein and X is a protein; cell-free; producing small cyclic peptides containing non-genetically encodable amino acids; for drugs |
| 01/18/2011 | US7871819 recombinant vector comprising a sequence encoding a heterologous polypeptide inserted between E4 and E3 transcription units of an ovine adenovirus genome; directing expression of a coding sequence in a cell; cancer |
| 01/18/2011 | US7871815 producing a protein by cloning an open reading frame encoding a protein into the nucleic acid sequence of SEQ ID 151, introducing the resulting nucleic acid sequence into a host cell and exposing the host cell to rhamnose, thereby inducing expression of the protein |
| 01/18/2011 | US7871804 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
| 01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
| 01/18/2011 | US7871797 proteolysis; recombinant vectors; transformants |
| 01/18/2011 | US7871796 Isolation of binding proteins with high affinity to ligands |
| 01/18/2011 | US7871795 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins |
| 01/18/2011 | US7871793 glycoproteins having alpha 1,4-linked N-acetylglucosamine residue from milk of mammal containing carrier polypeptide with alpha 1,4-N-acetylglucosaminyl transferase; for treatment or prevention of gastric ulcers |
| 01/18/2011 | US7871772 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders |
| 01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
| 01/18/2011 | US7871762 Hyperglycosylated hCG (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease |
| 01/18/2011 | US7871626 Modified influenza virus for monitoring and improving vaccine efficiency |
| 01/18/2011 | US7871622 Stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/18/2011 | US7871619 Using orphan receptors expressed on cell surfaces as screening tool in identifying modulating agents of cell proliferation; antitumor agents |
| 01/18/2011 | US7871615 Humanized antibodies that recognize beta amyloid peptide |
| 01/18/2011 | US7871613 Adjuvant therapy with the use of anti-glypican 3 antibody |
| 01/18/2011 | US7871611 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer |
| 01/18/2011 | US7871610 Antibodies to Tie1 ectodomain |
| 01/18/2011 | US7871607 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms |
| 01/18/2011 | CA2637795C Antagonists of interleukin-15 |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2212832C Thrombin preparation |
| 01/18/2011 | CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence |
| 01/13/2011 | WO2011006107A1 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions |
| 01/13/2011 | WO2011005786A2 Compositions and methods for enhancing production of a biological product |
| 01/13/2011 | WO2011005621A1 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering |
| 01/13/2011 | WO2011005481A1 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION |
| 01/13/2011 | WO2011004847A1 NOVEL HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 01/13/2011 | WO2011003968A1 A fungal protease and use thereof |
| 01/13/2011 | WO2011003600A1 METHOD FOR THE PURIFICATION OF INTERFERON-β |
| 01/13/2011 | WO2011003153A1 Method of increasing the expression yield of vitamin k-dependent proteins |
| 01/13/2011 | WO2010134686A3 Soluble myostatin pro-domain recombinant protein having myostatin inhibitory activity and use thereof |
| 01/13/2011 | WO2010120514A3 Antigen-binding proteins comprising recombinant protein scaffolds |
| 01/13/2011 | WO2010118337A3 Methods of enhancing yield of active iga protease |
| 01/13/2011 | WO2010075529A9 Heterologous biomass degrading enzyme expression in thermoanaerobacterium saccharolyticum |
| 01/13/2011 | WO2009158511A8 Factor viii muteins with reduced immunogenicity |
| 01/13/2011 | US20110010807 Starch branching enzyme |